4-Chloro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2,2,2-trifluoroethyl)-1H-indazol-3-amine

医药中间体 · — · —

医药中间体Confidentiality：公开

INN / Generic Name: 4-Chloro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2,2,2-trifluoroethyl)-1H-indazol-3-amine
Dosage Form: —
Strength: —
Therapy Area: Pharmaceutical Intermediates
Indication: API: Lenacapavir sodium
Current Status: 官方中间体目录（API: Lenacapavir sodium）
GMP Certification: —
CEP: No
DMF Type: —
Stability Data: —
BE Required: Not required / waivable
Registration Pathway: FSO 供货（非注册物质）
MOQ: 询价
Lead Time: 询价
Price Range: 询价

Registrable Markets

Global

Process / Sequence / Exact Price